Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-03-03 @ 4:15 PM
Study NCT ID:
NCT00560833
Status:
COMPLETED
Last Update Posted:
2019-04-02
First Post:
2007-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2006-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-01-15
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-16
First Submit QC Date:
None
Study First Post Date:
2007-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-28
Results First Submit QC Date:
None
Results First Post Date:
2014-06-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-25
Last Update Post Date:
2019-04-02
Last Update Post Date Type:
ACTUAL